A leading stem cell and genetics research laboratory

The essential key to triumph in the contention of bio-industry is to construct the technical unit with high quality in terms of both hardware and software.

Even before the market shares of cord blood banking reaches saturation in Taiwan, BIONET had already started research in mesenchymal stem cells. Subsequently, we are the first company to offer cryopreservation service specialized for mesenchymal stem cell in Asia. In accordance with rapid growing market demand, BIONET has invested more than 18.8 million USD to build a world-class corporate head quarter with core laboratories of stem cell and genetics technology. BIONET is keen on achieving the best quality in both hardware and software at once.

As the applications of stem cell become more and more diversified, database of stem cell will soon be employed as a source of cellular derivative products by medical centers, clinics, research institute and laboratory. By building up a laboratory comprised of quality parallel to international standards and outstanding research team as merely the first step, we at BIONET is aiming to become one of the leading companies in bio-industry globally.

Outstanding Consultant Team

Competition among bio-industry has become intense due to globalization. Therefore it is essential to build up connections for communicating and exchanging advanced information with world-class scholars and scientists, and to ensure constant updating and improvement. We at BIONET have the most outstanding consultant team to assist our research projects, in which includes Professor John Wagner, who is the pioneer in cord blood stem cell transplantation. Furthermore, the internationally recognized geneticist, Dr. Mark Hughes of Genesis Genetic Institute, has partnered with BIONET to introduce pre-implantation genetic diagnosis (PGD) to east Asia. The collaboration may provide an alternative option for couples with concern of family inherited disorders.

Professor Winston Kao of University of Cincinnati, has decades of devotion and expertise in a series of research projects targeting on MSC for corneal repair study. We at BIONET are truly honored and lifted by Dr. Kao’s advisory in MSC research. The most professional consultant team to BIONET has shown to be vital and irreplaceable for achieving the goal to surpass competitors in the most efficient manner.

Accredited Quality, Guarantee

The regulatory issue has shown to be highly influential to the biomedical industry as it should. As one of the major participants in the industry, BIONET has always actively complying and accommodating regional regulations, on top of self-demanding to meet global standards issued by premier organizations. Thus far, we have accreditation from：
Commission on Laboratory Accreditation (COLA)
American Association of Blood Banks (AABB)
Certificate of competency from Department of Health, Exexutive Yuan, R.O.C